1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)-3-(3-(trifluoromethoxy)phenyl)urea

ID: ALA4861929

PubChem CID: 164619937

Max Phase: Preclinical

Molecular Formula: C20H15F3N6O2

Molecular Weight: 428.37

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ccc(-c2cnc3ccc(NC(=O)Nc4cccc(OC(F)(F)F)c4)cc3n2)n1

Standard InChI:  InChI=1S/C20H15F3N6O2/c1-29-8-7-16(28-29)18-11-24-15-6-5-13(10-17(15)27-18)26-19(30)25-12-3-2-4-14(9-12)31-20(21,22)23/h2-11H,1H3,(H2,25,26,30)

Standard InChI Key:  NVXZWJRHVGIGTA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   40.3767  -13.9996    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   39.9722  -13.2938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5632  -13.9970    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.4563  -13.3515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4552  -14.1793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1673  -14.5883    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.1656  -12.9427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8783  -13.3479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8791  -14.1752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5917  -14.5823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3041  -14.1673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2994  -13.3411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5861  -12.9377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0087  -12.9282    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.7230  -13.3325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4324  -12.9196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.7280  -14.1538    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.1425  -13.3238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1432  -14.1451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8566  -14.5534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5669  -14.1363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5593  -13.3108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8453  -12.9103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7496  -12.9389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6649  -12.1262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8658  -11.9554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4564  -12.6628    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.0027  -13.2705    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.6436  -12.7474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2626  -12.8946    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.6779  -12.8793    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 24  2  0
  4 24  1  0
 27 29  1  0
 22 30  1  0
 30  2  1  0
  2 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4861929

    ---

Associated Targets(Human)

NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 428.37Molecular Weight (Monoisotopic): 428.1209AlogP: 4.57#Rotatable Bonds: 4
Polar Surface Area: 93.96Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.28CX Basic pKa: 1.24CX LogP: 4.72CX LogD: 4.72
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.50Np Likeness Score: -1.96

References

1. Sagar S, Singh S, Mallareddy JR, Sonawane YA, Napoleon JV, Rana S, Contreras JI, Rajesh C, Ezell EL, Kizhake S, Garrison JC, Radhakrishnan P, Natarajan A..  (2021)  Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.,  222  [PMID:34098465] [10.1016/j.ejmech.2021.113579]

Source